Who owns EVOKE PHARMA INC?
- Ticker: EVOK
- CUSIP Number: 30049g302
Tip: Access positions for across all investors
Analyze quarterly positions in Evoke Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Evoke Pharma stock
Who bought or sold EVOKE PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Nantahala Capital Management | 148k | $655k | 163% | Dec 2024 |
|
| AIGH Capital Management | 71k | $344k | 100% | Sep 2024 |
|
| Bleichroeder | 69k | $304k | 0% | Dec 2024 |
|
| UBS Group | 1.3k | $5.6k | 1298% | Dec 2024 |
|
| BlackRock | 122.00 | $538.996000 | 0% | Dec 2024 |
|
| SBI Securities | 75.00 | $332.002500 | 100% | Dec 2024 |
|
| Morgan Stanley | 31.00 | $137.001400 | 0% | Dec 2024 |
|
| Goss Wealth Management | 17.00 | $75.000600 | 0% | Dec 2024 |
|
| Bank of America Corporation | 9.00 | $39.999600 | -64% | Dec 2024 |
|
Who sold out of Evoke Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Corsair Capital Management | Sep 2024 | 12k | $56k |
| Tower Research Capital | Sep 2024 | 816.00 | $3.9k |